Celixir
Crafting regenerative medicines to enhance patients' lives through pioneering treatments for heart disease and tissue injuries.
Cardiff, United Kingdom
6 employees
Series Unknown
Total: $2.62M
Biotechnology, Health Care
General Information
Get notified when Celixir moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Celixir
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United Kingdom Market
Biotechnology
About Celixir
Taxonomy: Regenerative Medicine, Medical Research, Cell Therapy, Heart Disease, Tissue Injury, Medical Innovation, iMP Cells, Platelet Lysate, PML Cells, Ischaemic Heart Disease, Tendon Injury, Heart Failure, Medical Care, Patient Treatment
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 1 |
|
21 Mar 2018 |
| Venture Round | •••••• | - | 01 Dec 2014 | |
| Seed Round | •••••• | - | 01 Mar 2013 |
Celixir Alternatives & Competitors
Reprogram and regenerate. A revolution in medicine.
-Sci-&-Tech-Co.-logo.jpg "Zensun (Shanghai) Sci & Tech Co."){kind=logo}
Healing through innovation, delivering life-saving therapies for the unmet needs of tomorrow
Synova Life Sciences is a privately-owned biotechnology company that develops medical devices and me...
FAQ About Celixir
Don't just browse. Track.
Signal Tracker monitors Celixir and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.